Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Hagiwara, N. Hayashi, E. Mita, T. Takehara, A. Kasahara, H. Fusamoto, T. Kamada (1993)
Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy.Gastroenterology, 104 3
C. Poel, H. Reesink, H. Cuypers (1994)
Hepatitis C virus six years onThe Lancet, 344
Di Du, O. Hantz, M. Gouy, L. Vitvitski, Jisu Li, Françoise Berby, S. Tong, C. Trépo (1994)
Heterogeneity of hepatitis C virus genotypes in France.The Journal of general virology, 75 ( Pt 5)
Centre de Transfusion Sanguine, HBpital PitiC-Salp2trikre
G. Kuo, Q. Choo, H. Alter, G. Gitnick, A. Redeker, R. Purcell, T. Miyamura, J. Dienstag, M. Alter, C. Stevens (1990)
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.Science, 244 4902
M. Goodrick, S. Gray, A. Rouse, A. Waters, N. Anderson (1994)
Hepatitis C (HCV)‐positive blood donors in South‐West England: a case control studyTransfusion Medicine, 4
P. Das, A. Heethuis, R. Mcshine, C. Sibinga (1994)
Supplemental HCV antibody assay in blood donors by RIBA and line immunoassay *Transfusion Medicine, 4
Zaaijer Zaaijer, Cuypers Cuypers, Reesink Reesink (1993)
Reliability of polymerase chain reaction for detection of hepatitis C virusLancet, 341
P. Manzini, P. Calvo, M. Abate, A. Cerchier, P. Piantino, P. Vallauri, S. D’antico, B. Sympson, R. Klarmann, M. Schiffer (1994)
Asymptomatic anti-HCV seropositive subjects include patients with chronic active hepatitis and individuals with normal liver: can we distinguish them?Journal of hepatology, 21 1
J. Bukh, P. Wantzin, K. Krogsgaard, F. Knudsen, R. Purcell, R. Miller (1993)
High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group.The Journal of infectious diseases, 168 6
H. Zaaijer, H. Vrielink, P. Exel-Oehlers, H. Cuypers, P. Lelie (1994)
Confirmation of hepatitis C infection: a comparison of five immunoblot assaysTransfusion, 34
L. Stuyver, R. Rossau, A. Wyseur, M. Duhamel, B. Vanderborght, H. Heuverswyn, G. Maertens (1993)
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.The Journal of general virology, 74 ( Pt 6)
Yuki Yuki, Hayashi Hayashi, Kamada Kamada (1993)
HCV viraemia and liver injury in symptom‐free blood donors (letter)Lancet, 342
Relation - ship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C
M. Naito, N. Hayashi, H. Hagiwara, N. Hiramatsu, A. Kasahara, H. Fusamoto, T. Kamada (1994)
Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levelsHepatology, 19
Tumminelli Tumminelli, Marcellin Marcellin, Rizzo Rizzo (1995)
Shaving as potential source of hepatitis C virus infection (letter)Lancet, 345
L. Stuyver, A. Wyseur, W. Arnhem, Françoise Lunel, Pierre Laurent-Puig, J. Pawlotsky, B. Kleter, Leda Bassit, John Nkengasong, L. Doorn, G. Maertens (1995)
Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples.Virus research, 38 2-3
Ting Chang, T. Liou, K. Young, Xi-Zhang Lin, Ching‐Yih Lin, Jeng‐Shiann Shin, Hua-Lin Wu (1994)
Intrafamilial transmission of hepatitis C virus: The important role of inapparent transmissionJournal of Medical Virology, 42
J. Esteban, J. López-Talavera, Juan Genesca, P. Madoz, L. Viladomiu, E. Muñíz, C. Martín‐Vega, M. Rosell, H. Allende, X. Vidal, António Gonzalez, J. Hernández, R. Esteban, J. Guardia (1991)
High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.Annals of internal medicine, 115 6
J. Gournay, P. Marcellin, M. Martinot-Peignoux, F. Gabriel, S. Erlinger, J. Benhamou, C. Degott, F. Courtois, M. Branger, A. Wild (1995)
Hepatitis C virus genotypes in French blood donorsJournal of Medical Virology, 45
F. Mcomish, S. Chan, B. Dow, J. Gillon, W. Frame, R. Crawford, P. Yap, E. Follett, P. Simmonds (1993)
Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalitiesTransfusion, 33
(1994)
C (HCV)positive blood donors in south-west England: a case control study
A. Kroes, R. Man, H. Niesters, S. Schalm, W. Weimar, A. Balk (1994)
Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only.Journal of hepatology, 21 6
E. Dussaix, N. Charnaux, P. Laurent-Puig, S. Chopineau, Y. Laurian, C. Buffet (1994)
Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibodyJournal of Clinical Microbiology, 32
Masahiko Sugitani, Genevieve Inchauspe, A. Prince, M. Shindo (1992)
Sensitivity of serological assays to identify blood donors with hepatitis C viraemiaThe Lancet, 339
C. Poel, H. Reesink, J. Boven, H. Cuypers, I. Winkel, P. Exel-Oehlers, W. Schaasberg, P. Lelie, A. Weiner, A. Polito, S. Quan, R. Nello, M. Houghton, D. Mulder-Folkerts, A. Leentvaar‐Kuypers (1991)
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assayThe Lancet, 337
D. Osmond, N. Padian, H. Sheppard, Sarah Glass, S. Shiboski, A. Reingold (1993)
Risk factors for hepatitis C virus seropositivity in heterosexual couples.JAMA, 269 3
C. Poel, P. Lelie, Q. Choo, H. Reesink, A.Leent Vaar-Kuypers, G. Kuo, M. Houghton (1989)
ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDSThe Lancet, 334
Q. Choo, K. Richman, Jang Han, K. Berger, C. Lee, Christine Dong, C. Gallegos, D. Coit, R. Medina-Selby, P. Barr (1991)
Genetic organization and diversity of the hepatitis C virus.Proceedings of the National Academy of Sciences of the United States of America, 88
Visiting Scientist, Department of Clinical Chemistry, University of Ghent, Ghent; current address: Professor
C. Giannini, V. Thiers, J. Nousbaum, L. Stuyver, G. Maertens, C. Bréchot (1995)
Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes.Journal of hepatology, 23 3
Prieto Prieto, Olaso Olaso, Verdu Verdu (1995)
Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reactionHepatology, 22
J. Power, E. Lawlor, F. Davidson, E. Holmes, P. Yap, P. Simmonds (1995)
Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulinThe Lancet, 345
L. Doorn, G. Kleter, L. Stuyver, G. Maertens, J. Brouwer, S. Schalm, R. Heijtink, W. Quint (1995)
Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countries.The Journal of general virology, 76 ( Pt 7)
S. Aoki, P. Holland, L. Fernando, I. Kuramoto, S. Anderson, K. Sazama, V. Schoening, P. Johnson, J. Wilber, L. Fenner (1993)
Evidence of hepatitis in patients receiving transfusions of blood components containing antibody to hepatitis C.Blood, 82 3
A. Rossini, G. Gazzola, A. Ravaggi, E. Agostinelli, L. Biasi, A. Albertini, E. Radaeli, E. Cariani (1995)
Long‐term follow‐up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levelsTransfusion, 35
Garson Garson, Ring Ring, Tuke Tuke, Tedder Tedder (1990)
Enhanced detection by PCR of hepatitis C virus RNA (letter)Lancet, 336
F. Tumminelli, P. Marcellin, S. Rizzo, Salvatore Barbera, Goffredo Corvino, Patrice Furia, Jean-Piette Benhamou, S. Erlinger (1995)
Shaving as potential source of hepatitis C virus infectionThe Lancet, 345
J. Garson, C. Ring, P. Tuke, R. Tedder (1990)
Enhanced detection by PCR of hepatitis C virus RNAThe Lancet, 336
S. Moore, J. Kruger, J. Rakela, E. Vamvakas, C. Schimek, J. Germer, D. Persing (1995)
Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: evidence of failure to identify some risk factorsTransfusion, 35
(1995)
merase chain reaction for detection of hepatitis C virus
N. Yuki, N. Hayashi, T. Kamada (1993)
HCV viraemia and liver injury in symptom-free blood donorsThe Lancet, 342
J. Pawlotsky, Françoise Roudot-Thoraval, C. Pellet, Pascale Aumont, F. Darthuy, J. Rémiré, Jean-Roger Duval, D. Dhumeaux (1995)
Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patternsJournal of Clinical Microbiology, 33
Centre de Transfusion Sanguine
Viral LiPAs, Department of Nucleic Acid Chemistry
Kaoru Suzuki, Masashi Mizokami, Johnson Lau, N. Mizoguchi, Koji Kato, Yoshiki Mizuno, T. Sodeyama, K. Kiyosawa, T. Gojobori (1994)
Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis.The Journal of infectious diseases, 170 6
A. Alberti, G. Morsica, L. Chemello, D. Cavalletto, F. Noventa, P. Pontisso, A. Ruol (1992)
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCVThe Lancet, 340
(1995)
Mother‐to‐infant transmission of hepatitis C virusInternational Journal of Gynecology & Obstetrics, 51
A. Zanetti, E. Tanzi, S. Paccagnini, N. Principi, G. Pizzocolo, M. Caccamo, E. D'Amico, G. Cambié, L. Vecchi (1995)
Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission.Lancet, 345 8945
BACKGROUND: As only a few studies have examined the prevalence of various hepatitis C virus (HCV) subtypes in blood donors, information about the variability and route of infection in apparently healthy persons is limited. STUDY DESIGN AND METHODS: Blood donations collected at a large Parisian hospital (52,441) were investigated for antibodies to HCV. Serum samples were screened with an enzyme immunoassay. All HCV‐ positive donations were retested with a second enzyme immunoassay and confirmed by immunoblot. The HCV genotype was determined for all polymerase chain reaction‐positive subjects. Untypable genotypes were sequenced in the NS5B region. RESULTS: In total, 83 (0.26%) blood donors were anti‐HCV positive. Men (0.34%) were significantly more likely to be infected (p < 0.001) than women (0.19%). Prevalence rates in men between 20 and 39 years of age were higher than those in similar women (p = 0.01), but greater in women aged from 50 to 65 years (p = 0.05). Fifty‐five sera were viremic, of which 49 could be genotyped by a line probe assay. One new HCV type 1 subtype and three new HCV type 2 subtypes were discovered. In total, 28, 10, 11, 5, and 1 serum samples were grouped into HCV types 1 through 5, respectively, involving a total of 13 subtypes. The mean age of HCV type 2‐infected donors was 42 +/− 11 years, but that for type 3‐infected subjects was only 30 +/− 4 years (p = 0.0048). Forty‐nine subjects showed elevated alanine aminotransferase levels; 39 (80%) of these subjects were viremic (p < 0.05). CONCLUSION: Among the sampled population, an HCV prevalence rate of 0.26 percent was found, with the five most common European genotypes causing the infections. Four new subtypes were discovered. Correlation between genotype and risk factors was not apparent, but links with age, sex, and ethnic origin emerged.
Transfusion – Wiley
Published: Jun 1, 1996
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.